Europe Regenerative Medicines Market analysis with segmentation, drivers and restraints, size, share, trend analysis, growth, forecast, competitive landscape, key vendor analysis and mergers and acquisitions in the market.
The European regenerative medicines market is expected to reach USD XXmillion by 2022, from USD XXmillion in 2016, growing at a CAGR of XX%. Small molecules and biologics show immense potential for the market and are expected to grow at a CAGR of XX%. Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines, which are palliative.
Technological innovations in stem cell therapy and tissue engineering
Growing prevalence of bone and joint diseases
Growing need for orthopedic surgeries
Increase in awareness
Advancements in nanotechnology
The market is restrained by regulatory body rules, ethical issues related to regenerative medicines and cost of the treatment.
The market is segmented on the basis of technology into stem cell therapy, biomaterial, and tissue engineering. By type of applications, the market is segmented into bone graft substitutes, osteoarticular diseases, central nervous system, and cardiovascular. Based on geography, the market is segmented into the UK, France, Germany, Italy, Spain and Rest of Europe.
Some of the key players in this market include –
Neo Stem Inc.
Market analysis for the European regenerative medicines market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market.
Identification and analysis of the macro and micro factors that affect the European regenerative medicines market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Porters Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Degree of Competition
5.2.4 Threat of Substitution
5.2.5 Threat of New Entrants
6. Market Drivers, Restraints, Opportunities and Challenges (DROC) Analysis
6.1 Market Drivers
6.1.1 Technological Innovations in Stem Cell Therapy and Tissue Engineering
6.1.2 Growing Prevalence of Bone and Joint Diseases
6.1.3 Growing Need of Orthopedic Surgeries Fuels the Need of Global Regenerative Medicine Market
6.1.4 Increasing People Awareness
6.2 Market Restraints
6.2.1 Regulatory Constraints
6.2.2 Ethical Issues
6.2.3 Cost of Treatment
7. Market Segmentation
7.1 Segmentation by Type of Tests
7.1.1 Stem Cell Therapy
7.1.3 Tissue Engineering
7.2 Segmentation by Type of Applications
7.2.1 Bone Graft Substitutes
7.2.2 Osteoarticular Diseases
7.2.5 Central Nervous System
8. Segmentation by Geography
8.1.2 United Kingdom
8.1.6 Rest of Europe
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations, and Partnerships
10. Key Vendors
10.1 Anika Therapeutics, Inc.
10.2 Arthrex, Inc.
10.3 Baxter International, Inc.
10.4 Conmed Corporation
10.5 Depuy Synthes, Inc.
10.6 Medtronic, Inc.
10.7 Smith & Nephew Plc
10.8 Stryker Corporation
10.9 Zimmer Holdings, Inc.
11. Future Outlook of the Market